A project to identify new therapies for Alzheimer's disease receives funding from the Alzheimer's Association.
The Alzheimer’s Association will fund a project led by Dr. Arnaldo Parra-Damas to study molecular changes in inhibitory neurons that occur in Alzheimer’s disease.
The project, funded with $200,000, will be led by Dr. Arnaldo Parra-Damas, a Ramón y Cajal researcher at the Institute. It will also examine how these molecular changes impact the neural circuits involved in memory.
This research will investigate changes in gene expression and function of inhibitory neurons in the hippocampus during Alzheimer’s disease, using innovative genetic models and neural modulation tools.
The study aims to identify new therapeutic targets and early, specific biomarkers for this particular neuronal population, while also expanding understanding of the molecular mechanisms involved in this neurodegenerative disease.